Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems
Autonomix Medical has been granted U.S. Patent No. 12,544,131 for systems and devices that enable real-time monitoring and treatment of nerves through transvascular access. This patent enhances their intellectual property for next-generation neuromodulation technologies designed to objectively confirm nerve treatments and allow for real-time adjustments based on electrophysiological feedback.
Technology unlocks minimally invasive transvascular access to nerve targets and tissues through and beyond the lumen wall